Cholesterol depletion reduces the internalization of β-amyloid peptide in SH-SY5Y cells

Tsinghua Science and Technology

Volumn 11, Issue 4, 2006, Pages 447-451

  Zhou, Qinghua ^a   He, Li ^a   Sui, Senfang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cholesterol; Methyl cyclodextrin; amyloid peptides internalization

Indexed keywords

BRAIN; DEPOSITION; DISEASE CONTROL;

ALZHEIMER'S DISEASE; BETA-AMYLOID PEPTIDES INTERNALIZATION; METHYL-BETA-CYCLODEXTRIN;

CHOLESTEROL;

EID: 33749834126     PISSN: 10070214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1007-0214(06)70215-2     Document Type: Article

References (21)

1. Gursky O, Aleshkov S. Temperature-dependent beta-sheet formation in beta-amyloid A beta (1-40) peptide in water: Uncoupling beta-structure folding from aggregation. BBA-Protein Struct. M., 2000, 1476: 93-102.
2. Giovannelli L, Scali C, Faussone-Pellegrini M S, Pepeu G, Casamenti F. Long-term changes in the aggregation state and toxic effects of beta-amyloid injected into the rat brain. Neuroscience, 1998, 87: 349-357.
3. Lambert M P, Barlow A K, Chromy B A, Edwards C, Freed R, Liosatos M, Morgan T E, Rozovsky I, Trommer B, Viola K L, Wals P, Zhang C, Finch C E, Krafft G A, Klein W L. Diffusible, nonfibrillar ligands derived from A beta (1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sct. USA, 1998, 95: 6448-6453.
4. Ditaranto K, Tekirian T L, Yang A J. Lysosomal membrane damage in soluble A beta-mediated cell death in Alzheimer's disease. Neurobiology of Disease, 2001, 8: 19-31.
5. Giulian D, Haverkamp L J, Yu J H, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo Y M, Roher A E. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. Journal of Neuroscience, 1996, 16: 6021-6037.
6. Selkoe D J. Alzheimer's disease: Genes, proteins, and therapy. Physiological Reviews, 2001, 81: 741-766.
7. Knauer M F, Soreghan B, Burdick D, Kosmoski J, Glabe C G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. USA, 1992, 89: 7437-7441.
8. Burdick D, Kosmoski J, Knauer M F, Glabe C G. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Research, 1997, 746: 275-284.
9. Yang A J, Knauer M, Burdick D A, Glabe C. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. Journal of Biological Chemistry, 1995, 270: 14786-14792.
10. Takahashi R H, Nam E E, Edgar M, Gouras G K. Alzheimer beta-amyloid peptides: Normal and abnormal localization. Histology and Histopathology, 2002, 17: 239-246.
11. Jick H, Zornberg G L, Jick S S, Seshadri S, Drachman D A. Statins and the risk of dementia. Lancet, 2000, 356: 1627-1631.
12. Michikawa M. The role of cholesterol in pathogenesis of Alzheimer's disease-Dual metabolic interaction between amyloid beta-protein and cholesterol. Molecular Neurobiology, 2003, 27: 1-12.
13. Wolozin B, Kellman W, Ruosseau P, Celesia G G, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology, 2000, 57: 1439-1443.
14. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmannn K, Hennerici M, Beyreuther K, Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides A beta 42 and A beta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2001, 98: 5856-5861.
15. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti C G, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA, 1998, 95: 6460-6464.
16. Zhang F, Sui S. Internalization of trichosanthin via different endocytic mechanisms. Tsinghua Science and Technology, 2005, 10: 430-434.
17. Kremer J J, Pallitto M M, Sklansky D J, Murphy R M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry, 2000, 39: 10309-10318.
18. Wertkin A M, Turner R S, Pleasure S J, Golde T E, Younkin S G, Trojanowski J Q, Lee V M. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA, 1993, 90: 9513-9517.
19. Shearman M S, Hawtin S R, Tailor V J. The intracellular component of cellular 3-(4, 5-dimethylthiazol-2-Yl)-2, 5-diphenyltetrazolium bromide (Mtt) reduction is specifically inhibited by beta-amyloid peptides. Journal of Neurochemistry, 1995, 65: 218-227.
20. Kilsdonk E P C, Yancey P G, Stoudt G W, Bangerter F W, Johnson W J, Phillips M C, Rothblat G H. Cellular cholesterol efflux mediated by cyclodextrins. Journal of Biological Chemistry, 1995, 270: 17250-17256.
21. Neufeld E B, Cooney A M, Pitha J, Dawidowicz E A, Dwyer N K, Pentchev P G, Blanchette-Mackie E J. Intracellular trafficking of cholesterol monitored with a cyclodextrin. Journal of Biological Chemistry, 1996, 271: 21604-21613.